Glewed TV to Air Charles Mattocks' Groundbreaking TV Series "Eight Days"

Loading...
Loading...

Docu-series takes an inside look at what healing from cancer really looks like

NEWARK, Del. (PRWEB) August 07, 2020

Glewed TV, a leading video-on-demand (VOD) discovery, live distribution and monetization management platform for original and professionally produced video content, today announced a partnership with award-winning director Charles Mattocks to air Eight Days, a groundbreaking new television concept following the lives of real cancer patients. The first reality TV series of its kind, Eight Days first aired on the FYI Network on January 4, 2020 and gave viewers an inside look at what healing from cancer is really like.

"We are thrilled to bring this provocative series about survival to our viewers," said Melody Wolff, Chief Marketing Officer at Glewed TV. "Our viewers are engaged with our wide range of content and are sure to enjoy this new series!"

A continuation of Mattocks' diabetes docu-series Reversed, Eight Days examines the lives of five diverse individuals living with different stages of cancer and the experts who guide them on their healing journey. Major themes explored through the show include physical, emotional, and spiritual healing; how to treat the root of cancer instead of the symptoms; and the latest breakthroughs in non-toxic cancer treatment that lead to better health and quality of life in patients.

"It's a show unlike anything that's been seen before, with cancer survivors who share it all and experts who lovingly guide them to health and healing," says Hope4Cancer™ Founder and Chief Medical Officer, Dr. Antonio Jimenez.

Through raw storytelling and an investigative format, Eight Days aims to educate viewers and raise awareness for integrative cancer treatment options and practical disease management. With over 1.7 million cancer diagnoses documented per year in the U.S. alone, the show's relevant content and revolutionary delivery have the power and potential to affect millions of lives. For more information, visit the Eight Days official website.

About Charles Mattocks
Celebrity chef Charles Mattocks also known as The Poor Chef, nephew to the late reggae legend Bob Marley. He is an award winning film producer, as well as, an international diabetes advocate, IDF Blue Circle Champion, American Diabetes Association published author. Charles has made appearances on major talks shows around the country from CNN to Dr. Oz and more. As a best selling author and advocate, Charles was on the road to becoming a household name until his personal diagnosis of Type II diabetes. After such devastating news Charles started a global mission for not only his life, but also for the millions struggling with diabetes.

Eight Days was born out of a desire to help, embarking on season two with Hope4Cancer Treatment Centers™. Charles will tackle the disease cancer. Inspired by the loss of his father from lung cancer Charles wanted to create a tool to educate and inspire.

About Glewed TV
Glewed TV was founded by a team of creators and technologists that have successfully launched multiple streaming channels in the past five years. Glewed TV is one of the ways cord cutters are saving with free access to premium on-demand content. No subscription fees are required to watch movies and TV programs that are unique, engaging, immediate and convenient. Glewed TV is ad-supported and free across all platforms. Glewed TV sources and produces content of high production value with over 10,000 hours available. Main content categories include food, children, sports, DIY, educational, documentaries, animals/wildlife, travel, comedy, product reviews and movies.

For the original version on PRWeb visit: https://www.prweb.com/releases/glewed_tv_to_air_charles_mattocks_groundbreaking_tv_series_eight_days/prweb17310596.htm

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...